BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20632245)

  • 1. Topical recombinant human thrombin in surgical hemostasis.
    Bowman LJ; Anderson CD; Chapman WC
    Semin Thromb Hemost; 2010 Jul; 36(5):477-84. PubMed ID: 20632245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical thrombins: benefits and risks.
    Lomax C; Traub O
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):8S-12S. PubMed ID: 19558279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical use of recombinant human thrombin for operative hemostasis.
    Anderson CD; Bowman LJ; Chapman WC
    Expert Opin Biol Ther; 2009 Jan; 9(1):133-7. PubMed ID: 19063699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of three stand-alone topical thrombins for surgical hemostasis.
    Cheng CM; Meyer-Massetti C; Kayser SR
    Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
    Ofosu FA; Crean S; Reynolds MW
    Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.
    Chapman WC; Singla N; Genyk Y; McNeil JW; Renkens KL; Reynolds TC; Murphy A; Weaver FA
    J Am Coll Surg; 2007 Aug; 205(2):256-65. PubMed ID: 17660072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
    Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA;
    J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery.
    Doria C; Fischer CP; Wood CG; Li PM; Marra S; Hart J
    Curr Med Res Opin; 2008 Mar; 24(3):785-94. PubMed ID: 18241525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of surgical hemostasis: topical agents.
    Sileshi B; Achneck HE; Lawson JH
    Vascular; 2008; 16 Suppl 1():S22-8. PubMed ID: 18544302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human thrombin: in surgical hemostasis.
    Croxtall JD; Scott LJ
    BioDrugs; 2009; 23(5):333-8. PubMed ID: 19754221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of antibodies to the topical hemostat bovine thrombin.
    Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
    J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
    Rodgers GM
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving hemostasis in the surgical field.
    Boucher BA; Traub O
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):2S-7S. PubMed ID: 19558278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
    Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
    J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in topical thrombins.
    Kessler CM; Ortel TL
    Thromb Haemost; 2009 Jul; 102(1):15-24. PubMed ID: 19572062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of recombinant human thrombin and plasma-derived human alpha-thrombin.
    Bishop PD; Lewis KB; Schultz J; Walker KM
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():86-97. PubMed ID: 16673270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine thrombin: history, use, and risk in the surgical patient.
    Diesen DL; Lawson JH
    Vascular; 2008; 16 Suppl 1():S29-36. PubMed ID: 18544303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.
    Ballard JL; Weaver FA; Singla NK; Chapman WC; Alexander WA
    J Am Coll Surg; 2010 Feb; 210(2):199-204. PubMed ID: 20113940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coagulation cascade and surgical hemostasis. Introduction.
    Voils SA
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):1S. PubMed ID: 19558277
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombin products: economic impact of immune-mediated coagulopathies and practical formulary considerations.
    Voils SA
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):18S-22S. PubMed ID: 19558281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.